Like this interview? See related articles and videos:
- Challenges in Translational Approaches and Biomarkers in Neurodegeneration
- Nasal Spray Shows Remarkable Efficacy in Easing Social Anxiety: Vistagen’s Fasedienol Promises New Hope
- Interview with Valentina Mosienko, Fellow and Lecturer in Neuroscience, University of Bristol
- New Study Includes Pain Management Device for Chronic Symptoms of NFL Players
Join and network with over 450 industry discovery biology and chemistry leaders at the renowned Drug Discovery Summit in Basel, where they address critical strategies in target identification, validation
and HIT optimisation of small and large molecule drugs.
Together with Neuroscience Drug Development Europe, attendees especially benefit from a 2-day event addressing emerging strategies for the drug development of neuroscience and successful approaches
for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.